Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C

2Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Background/Aims: This study was conducted to clarify the sustained virological response (SVR) prediction ability of baseline and treatment-related factors in patients with chronic hepatitis C virus (HCV) infection. Methods: This retrospective study collected data at four tertiary referral hospitals between June 2004 and July 2012. Out of 476 patients, 330 treatment-naïve patients with chronic HCV infection were recruited. Pegylated interferon α-2a/-2b plus ribavirin was administered for either 24 or 48 weeks depending on the HCV genotype. The baseline and treatment-related predictive factors of SVR were evaluated by analyzing data measured before treatment (i.e., baseline) and during treatment. Results: SVR rates for genotypes 1 and 2 were 63% (97/154) and 79.5% (140/176), respectively (p = 0.001). Multivariate analysis for baseline factors revealed that young age (p = 0.009), genotype 2 (p = 0.001), HCV RNA level of < 800,000 IU/mL (p < 0.001), and a baseline platelet count of > 150 x 103/ΜL (p < 0.001) were significant SVR predictors, regardless of the genotype. In particular, predictive accuracy for achievement of SVR was 87.3% for a baseline platelet count of > 150 x 103/ΜL. In multivariate analysis for treatment-related factors, SVR was associated with achievement of a rapid virological response (RVR; p < 0.001), treatment adherence of ≥ 80/80/80 (p < 0.001). Conclusions: Young age, genotype 2, low HCV RNA level, RVR, and treatment adherence were significantly associated with SVR. In addition, platelet count was an independent predictive factor for SVR. Therefore, platelet count could be used to develop individualized treatment regimens and to optimize treatment outcomes in patients with chronic HCV infection.

References Powered by Scopus

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

5999Citations
N/AReaders
Get full text

Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C: A Randomized Study of Treatment Duration and Ribavirin Dose

2798Citations
N/AReaders
Get full text

Diagnosis, management, and treatment of hepatitis C: An update

2721Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Thrombocytopenia in virus infections

66Citations
N/AReaders
Get full text

Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Jun, B. G., Park, E. J., Lee, W. C., Jang, J. Y., Jeong, S. W., Kim, Y. D., … Kim, B. S. (2019). Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C. Korean Journal of Internal Medicine, 34(5), 989–997. https://doi.org/10.3904/kjim.2017.322

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

58%

Professor / Associate Prof. 4

33%

Researcher 1

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

56%

Pharmacology, Toxicology and Pharmaceut... 2

22%

Computer Science 1

11%

Arts and Humanities 1

11%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 1

Save time finding and organizing research with Mendeley

Sign up for free